Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
Saved in:
| Title: | Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies. |
|---|---|
| Authors: | Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Chahar D; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida., Jain MD; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany., Durante MA; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Kaddoura M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Maclachlan KH; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Jelinek T; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Davies FE; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Figura NB; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida., Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Mai EK; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Weisel K; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Usmani S; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Locke FL; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Schatz JH; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Blood cancer discovery [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 450-463. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
